Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
about
Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genesHepatic non-parenchymal cells: Master regulators of alcoholic liver disease?Chronic hepatitis C and liver fibrosis.The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeParsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNSAlcoholic liver disease: pathogenesis, management, and novel targets for therapyThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsCellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisAlcoholic liver disease: pathogenesis and new therapeutic targets.Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat dietMechanisms of hepatic fibrogenesisDevelopmental origins of NAFLD: a womb with a clue.Stress regulates endocannabinoid-CB1 receptor signaling.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisEndocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.Hepatitis C virus induces the cannabinoid receptor 1.Role of cannabinoids in the development of fatty liver (steatosis)New therapeutic targets in alcoholic hepatitis.Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid-dependent gut transit in ApoE-/- mice.Fibrogenesis in alcoholic liver disease.Molecular pathways in non-alcoholic fatty liver disease.Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss.Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma.The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets.The endocannabinoid system: potential for reducing cardiometabolic riskOveractive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteinsCannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controlsHepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.Addiction research centres and the nurturing of creativity: the National Institute on Alcohol Abuse and Alcoholism.Suppression of CB1 cannabinoid receptor by lentivirus mediated small interfering RNA ameliorates hepatic fibrosis in rats.Involvement of hepatic innate immunity in alcoholic liver disease.Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemiaAltered expression of type-1 and type-2 cannabinoid receptors in celiac diseaseEndocannabinoids in liver disease.Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liverHepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH.AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies.The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.
P2860
Q21090979-E8892CE9-F07D-4DB6-AECA-322E455B9AEFQ26773296-AC61A8B4-A857-4ECB-B429-E1CE65F369EBQ26825671-40592C5D-5677-48D0-870D-230C7470F147Q26850858-F3612ECF-DE65-4B89-80DF-F64493CBB569Q26853436-2E09D1A2-2A06-4389-B63B-372CE430C235Q26861620-720FF07F-F4BD-445C-BAD0-C4E3AB173829Q27009466-C42AF46A-D9B5-4E6F-BBA7-8627660F8B83Q27021577-5F4ACB06-8593-4B67-B0ED-79464269194FQ27690220-7E58E6B2-C5AE-4B1B-953F-281D87F39886Q28576328-A4CE81C9-4248-4CC3-8884-9B6368988BD9Q29619336-25D13E89-8B8D-4541-8E62-6D89569CEF98Q30241940-8BC464EB-3D0A-4E7E-A34D-3464678979FEQ30402136-E1E50889-637F-4D05-AA46-454579104A7BQ33464957-2E2AA57B-86F3-4324-B0FA-5088EE4D1D1AQ33597839-AF17B15B-B5A3-4A49-ABCC-77005C917066Q33700418-DE87F218-11D7-4780-BC3B-AC6A0FAC41BDQ33749478-B5C841A7-656D-49AC-ACE9-8FD544405E02Q33757267-0AA02006-8214-44FB-8743-BF757A838BAAQ33779386-7984FA64-A38E-4923-B959-67975309D98AQ33845463-7A033AED-4AB5-481E-923F-C0BDD16938B6Q33890230-9D757181-CC28-4FC5-B289-A7B4E092397EQ33908763-F3A40444-6F43-43BA-840D-DF64BFA2ED07Q33911192-D627D88F-598A-43AA-8DFF-5EC7FFD9EDE5Q33929406-FC553B04-55EA-4D16-9CC9-0747415DF1E6Q33997122-B2C28D3E-55DA-4441-8E93-920BEF8A2A41Q33999727-8811D650-E902-4FA4-AA16-53FF855A8F19Q34013800-2A3B7242-195B-4A74-A632-F999B316CD92Q34022349-F788F291-F858-4DB8-BF8C-C03AA8DCF95BQ34112535-1EE7BDBD-F2CC-4662-BF79-9403451B0582Q34507655-B7B00DF3-B3C1-4F64-B9FE-937E08C4CA21Q34515920-D95CC89A-6229-46CA-AB7B-13B30325A4F4Q34521006-3133B898-5262-4976-90C6-D59E989B2296Q34581048-587EA076-9400-4BFE-B987-8405E3734C4EQ34689405-488F7808-24C1-47EE-B1C3-1F780EA9E4E7Q34776919-6B073977-92DD-4E9E-A15F-AE32B073E5B8Q34794697-7A6C13D1-A6FA-4AC5-A90A-BF26E84B26A8Q34873332-DFC40940-0140-473C-BC43-9FDACF5856AFQ35048879-5920405C-E840-410F-B694-A1A8E1CCD6F3Q35053193-A3D74F6D-2E4A-4C17-8E69-14FE7744CDC5Q35122796-028EE20A-6CA4-42FD-A296-97E200136FFE
P2860
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@en
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@nl
type
label
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@en
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@nl
prefLabel
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@en
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@nl
P2093
P50
P1433
P1476
Paracrine activation of hepati ...... ediates alcoholic fatty liver.
@en
P2093
George Kunos
Judith Harvey-White
Norio Horiguchi
Sándor Bátkai
Won-il Jeong
P304
P356
10.1016/J.CMET.2007.12.007
P577
2008-03-01T00:00:00Z